APA Alıntı

Ribrag, V., Armand, P., Kuruvilla, J., Michot, J., Moskowitz, C. H., Marinello, P., . . . Zinzani, P. L. (2015). An open-label, multicohort Phase Ib trial of pembrolizumab (MK-3475) for advanced hematologic malignancies: KEYNOTE-013. J Immunother Cancer.

Chicago Stili Alıntı

Ribrag, Vincent, et al. "An Open-label, Multicohort Phase Ib Trial of Pembrolizumab (MK-3475) for Advanced Hematologic Malignancies: KEYNOTE-013." J Immunother Cancer 2015.

MLA Alıntı

Ribrag, Vincent, et al. "An Open-label, Multicohort Phase Ib Trial of Pembrolizumab (MK-3475) for Advanced Hematologic Malignancies: KEYNOTE-013." J Immunother Cancer 2015.